World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
59
Citations
12712
World Ranking
4001
National Ranking
344

Overview

Christoph Laske is affiliated with the University of Tübingen in Germany and has contributed extensively to medical and neuroscience research, particularly in the area of Alzheimer's disease and cognitive impairment.

The scientist's recent research papers include the following works:

  • Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease, 2022, JAMA Neurology
  • Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease, 2023, Nature Medicine
  • Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age, 2021, Neurology
  • Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers, 2022, Acta Neuropathologica
  • Minor neuropsychological deficits in patients with subjective cognitive decline, 2020, Neurology

Frequent co-authors who have collaborated with Christoph Laske include:

  • Oliver Peters
  • Josef Priller
  • Annika Spottke
  • Anja Schneider
  • Jens Wiltfang

Publication venues where Christoph Laske has often published work are:

  • Alzheimer s & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Alzheimer s Research & Therapy
  • Journal of Alzheimer s Disease
  • Neurology

The primary fields of study for this scientist center on Medicine and Neuroscience.

Subfields of study within these areas include:

  • Psychiatry and Mental health
  • Cognitive Neuroscience
  • Physiology
  • Neurology
  • Radiology, Nuclear Medicine and Imaging

The main topics explored in Christoph Laske's research encompass:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Functional Brain Connectivity Studies
  • Advanced Neuroimaging Techniques and Applications
  • Nutritional Studies and Diet
  • Diet and metabolism studies
  • Neurological Disease Mechanisms and Treatments

Best Publications

  • Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

    Oliver Preische;Oliver Preische;Stephanie A. Schultz;Anja Apel;Anja Apel;Jens Kuhle

  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.

    Nicolas R Barthélemy;Yan Li;Nelly Joseph-Mathurin;Brian A Gordon

  • White Matter Hyperintensities Are a Core Feature of Alzheimer's Disease: Evidence from the Dominantly Inherited Alzheimer Network

    Seonjoo Lee;Fawad Viqar;Fawad Viqar;Molly E. Zimmerman;Molly E. Zimmerman;Atul Narkhede

  • Stage-dependent BDNF serum concentrations in Alzheimer’s disease

    C. Laske;E. Stransky;T. Leyhe;G. W. Eschweiler

  • Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid

    Unknown

  • Innovative diagnostic tools for early detection of Alzheimer's disease

    Christoph Laske;Christoph Laske;Hamid R. Sohrabi;Hamid R. Sohrabi;Shaun M. Frost;Karmele López-de-Ipiña

  • BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

    Christoph Laske;Elke Stransky;Thomas Leyhe;Gerhard W. Eschweiler

  • Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

    Sid E. O'Bryant;Veer Gupta;Kim Henriksen;Melissa Edwards

  • Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).

    Frank Jessen;Frank Jessen;Annika Spottke;Annika Spottke;Henning Boecker;Henning Boecker;Frederic Brosseron

  • Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial.

    Uwe Herwig;Andreas J. Fallgatter;Jacqueline Höppner;Gerhard W. Eschweiler

  • 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial

    Hilkka Soininen;Alina Solomon;Alina Solomon;Alina Solomon;Pieter Jelle Visser;Pieter Jelle Visser;Suzanne B Hendrix

  • Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients

    Christoph Laske;Konstantinos Stellos;Nadine Hoffmann;Elke Stransky

  • Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression.

    Christoph Laske;Sabine Banschbach;Elke Stransky;Sabine Bosch

  • Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.

    Christoph Laske

  • Altered lymphocyte distribution in Alzheimer’s disease

    Elke Richartz-Salzburger;Anil Batra;Elke Stransky;Christoph Laske

  • Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.

    Thomas Leyhe;Gerhard W. Eschweiler;Elke Stransky;Thomas Gasser

  • Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease.

    T. Leyhe;Elke Stransky;G. W. Eschweiler;G. Buchkremer

  • Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

    Unknown

  • Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants

    Christoph Laske;Elke Stransky;Gerhard W. Eschweiler;Reinhild Klein

  • Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age.

    Tommaso Ballarini;Debora Melo van Lent;Debora Melo van Lent;Julia Brunner;Alina Schröder

  • Predictive Value of Platelet Activation for the Rate of Cognitive Decline in Alzheimer's Disease Patients:

    Konstantinos Stellos;Victoria Panagiota;Andreas Kögel;Thomas Leyhe

  • Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).

    Mengxuan Tang;Davis C. Ryman;Eric McDade;Mateusz S. Jasielec

  • White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network

    Seonjoo Lee;Fawad Viqar;Molly E. Zimmerman;Atul Narkhede

Frequent Co-Authors

Oliver Peters
Oliver Peters German Center for Neurodegenerative Diseases
Katharina Buerger
Katharina Buerger Ludwig-Maximilians-Universität München
Emrah Düzel
Emrah Düzel German Center for Neurodegenerative Diseases
Michael T. Heneka
Michael T. Heneka University Hospital Bonn
Stefan J. Teipel
Stefan J. Teipel German Center for Neurodegenerative Diseases
Peter R. Schofield
Peter R. Schofield Neuroscience Research Australia
Randall J. Bateman
Randall J. Bateman Washington University in St. Louis
John C. Morris
John C. Morris Washington University in St. Louis
Jasmeer P. Chhatwal
Jasmeer P. Chhatwal Harvard University
Tammie L.S. Benzinger
Tammie L.S. Benzinger Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Christoph Laske

Trending Scientists

Recently Published Articles